首页> 外文OA文献 >Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study

【2h】

Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study

机译：胰高血糖素样肽-1受体激动剂治疗属性对初次注射的2型糖尿病患者很重要：一项跨国研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Lei Qin; Stephanie Chen; Emuella Flood; Alka Shaunik; Beverly Romero; Marie de la Cruz; Cynthia Alvarez; Susan Grandy;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Na?ve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study [J] . Lei Qin, Stephanie Chen, Emuella Flood, Diabetes therapy . 2017,第2期

机译：胰高血糖素样肽1受体激动剂的治疗属性对初次注射的2型糖尿病初治患者很重要：一项跨国研究
2. Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom [J] . Lei Qin, Stephanie Chen, Emuella Flood, Diabetes therapy . 2017,第2期

机译：胰高血糖素样肽1受体激动剂治疗属性对有注射经验的2型糖尿病患者很重要：在德国和英国的偏好研究
3. Utilization patterns of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus in Germany: a retrospective cohort study [J] . Otto Thorsten, Myland Melissa, Jung Heike, Current medical research and opinion . 2019,第5期

机译：德国2型糖尿病患者的胰高血糖素样肽-1受体激动剂的利用模式：回顾性队列研究
4. Treatment of Diabetes and Obesity by Rationally Designed Peptide Agonists Functioning at Multiple Metabolic Receptors [C] . Noushafarin Khajavi, Heike Biebermann, Matthias Tschop, ESPE Advanced Seminar in Developmental Endocrinology . 2017

机译：通过在多种代谢受体中起作用的合理设计肽激动剂治疗糖尿病和肥胖症
5. Combinatorial targeting of the glucagon-like peptide-1 and sulfonylurea-1 receptors using a complimentary mulitvalent glucagon-like peptide-1/glibenclamide ligand for the improvement of beta-cell targeting agents and diabetic treatment. [D] . Hart, Nathaniel. 2013

机译：使用互补的多价胰高血糖素样肽-1 /格列苯脲酰胺配体对胰高血糖素样肽-1和磺酰脲-1受体进行联合靶向，以改善β细胞靶向剂和糖尿病治疗。
6. Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study [O] . Lei Qin, Stephanie Chen, Emuella Flood, 2017

机译：胰高血糖素样肽-1受体激动剂治疗属性对初次注射的2型糖尿病患者很重要：一项跨国研究
7. Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom [O] . 2017

机译：胰高血糖素样肽1受体激动剂的治疗属性对有注射经验的2型糖尿病患者很重要：在德国和英国的偏好研究

Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study

著录项

引文网络

相似文献

相关主题

期刊订阅